Trials / Conditions / Metastatic Neuroendocrine Tumors
Metastatic Neuroendocrine Tumors
3 registered clinical trials studyying Metastatic Neuroendocrine Tumors — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic N NCT07404176 | Tata Memorial Hospital | Phase 2 |
| Completed | Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET) NCT00610129 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors NCT00590343 | Louisiana State University Health Sciences Center in New Orleans | Phase 2 |